Richard W. Fitch

Richard W. Fitch

Auto-generated profile, based on publicly available information

Richard W. Fitch

Department of Chemistry and Physics, Indiana State University

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RFRichard W. Fitch
Richard W. Fitch
YXYingxian Xiao
Yingxian Xiao
KKKenneth J. Kellar
Kenneth J. Kellar
JDJohn W. Daly
John W. Daly
Seven cell lines expressing native and transfected nicotinic receptor subtypes were evaluated functionally by using fluorescent assays based on membrane potential and calcium dynamics with “no-wash” dye systems. Both assays provided the same rank orders of potency for (±)-epibatidine, 2 S -(−)-nicotine, 7 R ,9 S -(−)-cytisine, and 1,1-dimethyl-4-phenylpiperazinium in a cell line expressing rat α3β4 receptors. Nicotinic antagonists mecamylamine and dihydro-β-erythroidine inhibited responses in both assays. Both agonist and antagonist activity were assessed within the same experiment. Agonists seemed more potent in the membrane potential assay than in the calcium assay, whereas the converse was true for antagonists. The membrane potential assay afforded robust responses in K-177 cells expressing human α4β2 receptors, in IMR-32 and SH-SY5Y cells expressing human ganglionic receptors, and in TE-671 cells expressing human neuromuscular receptors. These lines gave weak to modest calcium responses. Moreover, membrane potential responses were obtained in cell lines expressing rat α4β2 and α4β4 receptors, which were devoid of calcium responses. Thus, membrane potential serves as a sensitive measure of nicotinic activity, and the resulting depolarization may be as important as calcium in cell signaling.

1 October 2003 in Journal of Natural Products
Verified
Journal Article
Closed access
RFRichard W. Fitch
Richard W. Fitch
HGH. Martin Garraffo
H. Martin Garraffo
TSThomas F. Spande
Thomas F. Spande
HYHerman J. C. Yeh
Herman J. C. Yeh
JDJohn W. Daly
John W. Daly

1 October 2011 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
TNTracy M. Neher
Tracy M. Neher
DBDiane Bodenmiller
Diane Bodenmiller
RFRichard W. Fitch
Richard W. Fitch
SJShadia I. Jalal
Shadia I. Jalal
John J. TurchiJohn J. Turchi
John J. Turchi
Replication protein A (RPA) is a single-strand DNA-binding protein with essential roles in DNA replication, recombination, and repair. It is necessary for the formation of the preincision complex that is required for proper incision of damaged DNA nucleotides during DNA repair. We have previously identified small molecule inhibitors (SMI) with the ability to disrupt RPA-binding activity to ssDNA. Further characterization of these RPA inhibitors was done using both lung and ovarian cancer cell lines. Lung cancer cell lines showed increased apoptotic cell death following treatment with the SMI MCI13E, with IC50 values of approximately 5 μmol/L. The ovarian cancer cell line A2780 and the p53-null lung cancer cell line H1299 were particularly sensitive to MCI13E treatment, with IC50 values less than 3 μmol/L. Furthermore, a cell-cycle effect was observed in lung cancer cell lines that resulted in a lengthening of either G1 or S-phases of the cell cycle following single-agent treatment. Sequential treatment with MCI13E and cisplatin resulted in synergism. Overall, these data suggest that decreasing DNA-binding activity of RPA via a SMI may disrupt the role of RPA in cell-cycle regulation. Thus, SMIs of RPA hold the potential to be used as single-agent chemotherapeutics or in combination with current chemotherapeutic regimens to increase efficacy. Mol Cancer Ther; 10(10); 1796–806. ©2011 AACR.

26 March 2010 in Journal of Natural Products
Verified
Journal Article
Closed access
RFRichard W. Fitch
Richard W. Fitch
TSThomas F. Spande
Thomas F. Spande
HGH. Martin Garraffo
H. Martin Garraffo
HYHerman J. C. Yeh
Herman J. C. Yeh
JDJohn W. Daly
John W. Daly

25 June 1999 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
FLFrederick A. Luzzio
Frederick A. Luzzio
RFRichard W. Fitch
Richard W. Fitch

1 July 1999 in Journal of Chemical Education
Verified
Journal Article
Closed access
FLFrederick A. Luzzio
Frederick A. Luzzio
RFRichard W. Fitch
Richard W. Fitch
WMWilliam J. Moore
William J. Moore
KMKelli J. Mudd
Kelli J. Mudd